Summary
Dr Tricia Tan is a Consultant in Diabetes, Endocrinology and Metabolic Medicine at Imperial College London and NHS Trust. She possesses over 10 years’ experience in gut hormone research and physiological studies into the impact of gut hormones on weight and T2DM. She has completed several Phase I trials on the gut hormone analogues, which are being developed for the treatment of obesity. She is the director of the SAS Gut Hormone service, and her clinical research spans a wide gamut from the diagnosis and treatment of neuroendocrine tumours to diagnostic testing in Endocrine disorders.
Publications
Journals
Izzi-Engbeaya C, Comninos AN, Clarke SA, et al., 2018, The effects of kisspeptin on beta-cell function, serum metabolites and appetite in humans, Diabetes Obesity & Metabolism, Vol:20, ISSN:1462-8902, Pages:2800-2810
Alexiadou K, Anyiam O, Tan T, 2018, Cracking the combination: gut hormones for the treatment of obesity and diabetes, Journal of Neuroendocrinology, ISSN:0953-8194, Pages:e12664-e12664
Conference
Kamocka A, McGlone ER, Pevida BP, et al., 2018, SURGICAL REVISION OF CANDY CANE AFTER ROUX-EN-Y GASTRIC BYPASS, 23rd World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), SPRINGER, Pages:232-232, ISSN:0960-8923
Tharakan G, Miras A, Chahal H, et al., 2018, BARIATRIC SURGERY OUTCOMES IN THE OVER-60S: A SINGLE CENTRE, OBSERVATIONAL STUDY FROM 2007-2012., 23rd World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), SPRINGER, Pages:376-376, ISSN:0960-8923
Szepietowski O, Alsters SI, Mahir G, et al., 2018, PREDICTING REMISSION OF NON-INSULIN TREATED TYPE 2 DIABETES AFTER RYGB, 23rd World Congress of the International-Federation-for-the-Surgery-of-Obesity-and-Metabolic-Disorders (IFSO), SPRINGER, Pages:191-191, ISSN:0960-8923